ASIA WORK: Open Payments
NPI 1316135684 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 19 payments from 11 companies in 2025. Trend: 2023 $879 · 2024 $587 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 5 | $138 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| Lilly USA, LLC | 3 | $58 |
| Inspire Medical Systems, Inc. | 2 | $51 |
| Optinose US, Inc. | 1 | $28 |
| PFIZER INC. | 2 | $28 |
| GENZYME CORPORATION | 1 | $25 |
| ABBVIE INC. | 1 | $16 |
| Verona Pharma, Inc. | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: DUPIXENT, Haegarda, ZEPBOUND, Andembry, INSPIRE, Xhance, NURTEC ODT, UBRELVY.
Industry payments across KY — which companies pay providers there.
